Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 September 2021 | Story Marius Coetzee and Rulanzen Martin | Photo Supplied
From the left: Werner Stolze of Stolze Pianos (sponsor), Karlin Kock (Trio Con Brio), Dr Mageshen Naidoo (adjudicator – UP), Kagiso Ramosa (Trio Con Brio), Renette Bouwer (adjudicator – UJ), Maria Yasbeck (Trio Con Brio), and Prof Wessel van Wyk from UP.

The Trio Con Brio ensemble in the Odeion School of Music (OSM) was crowned winners of the open category during the final round of the national SASMT Ensemble competition, which took place on 22 September 2021.  The Trio Con Brio comprises OSM students Kagiso Ramosa (clarinet), Maria Yasbeck (violin), and Karlin Kock (piano).

OSM lecturers, Drs Danre Strydom, Sharon de Kock, and Anneke Lamont served as instructors and mentors during the preparation phase. “The trio prepared their concert programme with an interesting methodology, by having weekly instruction from all lecturers individually on a rotation basis,” says Marius Coetzee, Artistic Director of the Odeion School of Music Camerata (OSMC). Elsabé Raath serves as the principal instructor. 

The OSMC took second place in the concert programme, while the instructor of the OSM Brass Quintet, George Foster, and the convenor, Quinn Kakora, were also selected to participate in the first round of the competition. Their recital was highly ranked and came third in the first round.

 SASMT competition develops young musicians 

The first SASMT Pretoria Ensemble Competition took place in September 2017. It would be the first competition of this nature to be held in the northern region of South Africa. The goal was to create an opportunity for young musicians to compete in groups, rather than focusing on solo performances. The feedback from the initial competition was overwhelmingly positive, culminating in the decision to make it an annual event.

The competition aims to develop young musicians through collaborative participation and by encouraging the enjoyment of performing with others. Another objective is to foster understanding, love, and appreciation for ensemble music and the performance thereof among young musicians. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept